Changes in AKT pathway activity can alter tumor cell migratory, invasion, and autophagic activity, making this pathway a promising target for therapeutic intervention in OC [9–12], with several PI3K/AKT/mTOR pathway inhibitors having shown promise in the OC treatment in the clinic [9]. The gene discussed is PIK3CA; the disease is neoplasm.